Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-15
2011-03-15
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S129000
Reexamination Certificate
active
07906510
ABSTRACT:
Disclosed is a compound having a strong affinity to serotonin-4 receptors, which is useful as an enterokinesis-promoting agent or a digestive tract function-improving agent. Specifically, disclosed is a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. Also specifically disclosed is a pharmaceutical composition containing a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. [In Formula (1), Ar represents a group represented by Formula (Ar-1) or Formula (Ar-2).]
REFERENCES:
patent: 4870074 (1989-09-01), Kon et al.
patent: 5395832 (1995-03-01), Ito et al.
patent: 6100262 (2000-08-01), Hendrickx et al.
patent: 6294555 (2001-09-01), Kato et al.
patent: 6696468 (2004-02-01), Kato et al.
patent: 0 243 959 (1987-11-01), None
patent: 63-264467 (1988-11-01), None
patent: 11-1472 (1999-01-01), None
patent: 11-505815 (1999-05-01), None
patent: 2000-80081 (2000-03-01), None
patent: 2001-122784 (2001-05-01), None
patent: 2004-43453 (2004-02-01), None
patent: 2004-277318 (2004-10-01), None
patent: 2004-277319 (2004-10-01), None
patent: 2004-277320 (2004-10-01), None
patent: 2005-82508 (2005-03-01), None
patent: 2005-082508 (2005-03-01), None
patent: 2005-104896 (2005-04-01), None
patent: 2005-170933 (2005-06-01), None
patent: 92/14705 (1992-09-01), None
patent: 96/37486 (1996-11-01), None
International Search Report issued Mar. 24, 2009 in International (PCT) Application No. PCT/JP2009/053011.
D. A. Craig et al., “Pharmacological Characterization of a Neuronal Receptor for 5 -Hydroxytryptamine in Guinea Pig Ileum with Properties Similar to the 5-Hydroxytryptamine4Receptors1”, The Journal of Pharmacology and Experimental Therapeutics, vol. 252, No. 3, pp. 1378-1386, 1990.
N. Yoshida et al., “AS-4370, A New Gastrokinetic Agent, Enhances Upper Gastrointestinal Motor Activity in Conscious Dogs”, The Journal of Pharmacology and Experimental Therapeutics, vol. 257, No. 2, pp. 781-787, 1991.
S. Kato et al., “Synthesis of a New Benzamide with Potent Gastric Prokinetic Activity”, Journal of Pharmaceutical Sciences, vol. 76, No. 11, p. S159, Nov. 1987.
S. Kato et al., “Synthesis and Structure-Activity Relationships of a New Gastroprokinetic Agent, AS-4370, and the Related Compounds”, J. Pharmacobio-Dyn., vol. 13, p. S146, 1990.
S. Kato et al., “Novel Benzamides as Selective and Potent Gastric Prokinetic Agents. 1. Synthesis and Structure-Activity Relationships of N-[(2-Morpholinyl)alkyl]benzamides”, J. Med. Chem., vol. 33, pp. 1406-1413, 1990.
S. Kato et al., “Novel Benzamides as Selective and Potent Gastrokinetic Agents. 2. Synthesis and Structure-Activity Relationships of 4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzy1)-2-morpholinyl]methyl]benzamide Citrate (AS-4370) and Related Compounds”, J. Med. Chem., vol. 34, pp. 616-624, 1991.
S. Kato et al., “Novel Benzamides as Selective and Potent Gastrokinetic Agents. III. Synthesis and Structure-Activity Relationships of 4-Amino-5-chloro-2-methoxy- and 2-Ethoxy-N-[(4-substituted 2-morpholinyl)methyl]-benzamides”, Chem. Phar. Bull., vol. 40, No. 3, pp. 652-660, 1992.
S. Kato et al., “Novel Benzamides as Selective and Potent Gastrokinetic Agents. IV. Synthesis and Structure-Activity Relationships of 2-Substituted 4-Amino-N-[(4-benzyl-2-morpholinyl)methyl]-5-chlorobenzamides”, Chem. Pharm. Bull., vol. 40, No. 6, pp. 1470-1475, 1992.
N. Yoshida et al., “Pharmacological Effects of the New Gastroprokinetic Agent Mosapride Citrate and its Metabolites in Experimental Animals”, Arzneim.Forsch./Drug Res., vol. 43, No. 10, pp. 1078-1083, 1993.
N. Yoshida et al., “Mosapride Citrate”, Drugs of the Future, vol. 18, No. 6, pp. 513-515, 1993.
T. Morie et al., “Synthesis and Biological Activities of the Optical Isomers (±)-4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzy1)-2-morpholinyl]methyl]benzamide (Mosapride)”, Chem. Pharm. Bull., vol. 42, No. 4, pp. 877-882, 1994.
T. Morie et al., “Asymmetric Synthesis of the Enantiomers of 2-Aminomethyl-4-(4-Fluorobenzyl)Morpholine, An Intermediate of Mosapride, A Gastroprokinetic Agent”, Heterocycles, vol. 38, pp. 1033-1040, 1994.
S. Kato et al., “Synthesis and Gastroprokinetic Activity of 2-Amino-N-[(benzyl-2-morpholinyl)methyl]benzamide Derivatives”, Chem. Phar. Bull., vol. 43, No. 4, pp. 582-587, 1995.
S. Kato et al., “Synthesis and Biological Activities of Metabolites of Mosapride, A New Gastroprokinetic Agent”, Chem. Pharm. Bull., vol. 43, No. 4, pp. 699-702, 1995.
S. Kato et al., “Synthesis and Gastroprokinetic Activity ofN-(4-amino-5-chloro-2-methoxypheny1)-4-benzyl-2-morpholineacetamide and Related Compounds”, Eur. J. Med. Chem., vol. 30, pp. 609-616, 1995.
S. Kato et al., “Synthesis of Deuterated Mosapride Citrate”, Journal of Labelled Compounds and Radiopharmaceuticals, vol. 36, No. 10, pp. 927-932, 1995.
S. Kato et al., “Synthesis and Biological Activity of 4-Amino-5-chloro-2-ethoxy-3-hydroxybenzamides, Metabolites of a New Gastroprokinetic Agent, Mosapride”, Chem. Pharm. Bull., vol. 44, No. 8, pp. 1484-1492, 1996.
S. Kato et al., “Synthesis of 4-Chloro-7-ethoxy-2(3H)-benzoxazolone-6-carboxylic Acid”, J. Heterocyclic Chem., vol. 33, pp. 1171-1178, 1996.
S. Kato et al., “Nitrogen-Containing Heteroalicycles with Serotonin Receptor Binding Affinity: Development of Gastroprokinetic and Antiemetic Agents”, Med. Res. Rev., vol. 19, pp. 25-73, 1999.
English translation of International Preliminary Report on Patentability and Written Opinion dated Oct. 5, 2010.
Harada Hiroshi
Hirokawa Yoshimi
Kan Yoko
Kato Shiro
Nakamura Takanori
Anderson Rebecca L
Dainippon Sumito Pharma Co., Ltd.
Shterengarts Samantha L
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Amide derivative and pharmaceutical composition containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivative and pharmaceutical composition containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivative and pharmaceutical composition containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2774996